Concept information
Preferred term
Methyl Methanesulfonate
Type
-
mesh:Descriptor
Definition
- An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.
Broader concept
Entry terms
- 66-27-3 (Methyl Methanesulfonate)
- AT5C31J09G
- Mesilate, Methyl
- Methanesulfonic acid, methyl ester
- Methylmesilate
- Methyl Mesylate
- Methylmethane Sulfonate
- Methyl Methylenesulfonate
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
66-27-3 (Methyl Methanesulfonate)
-
AT5C31J09G
-
Mésilate de méthyle
-
Mésylate de méthyle
-
Methanesulfonic acid, methyl ester
URI
http://data.loterre.fr/ark:/67375/JVR-BDTJQ4G2-1
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}